dacarbazine has been researched along with Carcinoma, Medullary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Licitra, L; Locati, LD | 1 |
| Hamilton, G; Kaczirek, K; Mittlböck, M; Niederle, B; Passler, C; Pfragner, R; Prager, G; Raderer, M; Scheuba, C; Schindl, M; Siegl, V; Weinhäusel, A | 1 |
| Goldenberg, DM; Stein, R | 1 |
| Moley, JF; Quayle, FJ | 1 |
| Abdelmoumene, N; Couette, JE; Delisle, MJ; Schlumberger, M | 1 |
| Angeli, A; Berruti, A; Caraci, P; Dogliotti, L; Orlandi, F; Pivano, G; Puligheddu, B | 1 |
| Averbuch, SD; Ball, DW; Baylin, SB; de Bustros, A; McGuire, WP; Wu, LT | 1 |
| Becker, W; Behr, TM; Blumenthal, RD; Dunn, RM; Gratz, S; Radetzky, S; Raue, F; Rave-Fränk, M; Schmidberger, H; Wulst, E | 1 |
| Baudin, E; Cailleux, AF; Mechelany-Corone, C; Nocera, M; Pellegriti, G; Schlumberger, M | 1 |
| Chen, S; Goldenberg, DM; Reed, L; Richel, H; Stein, R | 1 |
1 review(s) available for dacarbazine and Carcinoma, Medullary
| Article | Year |
|---|---|
Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Endocrine Surgical Procedures; Fluorouracil; Humans; Lymph Node Excision; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Parathyroidectomy; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Thyroidectomy; Transplantation, Autologous | 2005 |
4 trial(s) available for dacarbazine and Carcinoma, Medullary
| Article | Year |
|---|---|
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Radiotherapy, Adjuvant; Streptozocin; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 1995 |
Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Dacarbazine; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia; Thyroid Neoplasms | 1994 |
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Middle Aged; Thyroid Neoplasms; Vincristine | 1994 |
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Streptozocin; Thyroid Neoplasms; Treatment Outcome | 2000 |
5 other study(ies) available for dacarbazine and Carcinoma, Medullary
| Article | Year |
|---|---|
Multikinase inhibitors in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Clinical Trials as Topic; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Iodine Isotopes; Molecular Targeted Therapy; Multiple Endocrine Neoplasia Type 2a; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms | 2012 |
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Medullary; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Humans; Paclitaxel; Thyroid Neoplasms | 2004 |
A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Dacarbazine; Humans; Mice; Mice, Nude; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Immunoglobulin G; Iodine Radioisotopes; Mice; Mice, Nude; Radioimmunotherapy; Radionuclide Imaging; Streptozocin; Thyroid Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Female; Mice; Mice, Nude; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2002 |